Showing results (141-150 of 643) with videos related to
Sort By:
Pageof 65
Antimicrobial Agents and Chemotherapy|March 18, 2000
Risk factors for recovery of ampicillin-sulbactam-resistant Escherichia coli in hospitalized patientsK S Kaye, A D Harris, H Gold, et al.Antimicrobial Agents and Chemotherapy|August 22, 2025
New Perspectives on Antimicrobial Agents: Sulbactam-durlobactamJason M Pogue, Jeffrey Harrington, Walaiporn Wangchinda, et al.Emerging Infectious Diseases|June 23, 2004
Reference group choice and antibiotic resistance outcomesKeith S Kaye, John J Engemann, Essy Mozaffari, et al.Journal of Virological Methods|December 22, 1999
A quantitative PCR method for the assay of HIV-1 provirus load in peripheral blood mononuclear cellsJ M Bennett, S Kaye, N Berry, et al.Pharmacotherapy|September 20, 2011
Revisiting "older" antimicrobials in the era of multidrug resistanceJason M Pogue, Dror Marchaim, Donald Kaye, et al.European Journal of Cancer & Clinical Oncology|May 1, 1989
Phase II studies of mitozolomide in melanoma, lung and ovarian cancerM Harding, V Docherty, R Mackie, et al.Cancer|July 15, 1995
Entry and evaluation of elderly patients in European Organization for Research and Treatment of Cancer (EORTC) new-drug-development studiesS Monfardini, R Sorio, G H Boes, et al.Journal of Medical Virology|February 1, 1991
Intrathecal IgG synthesis and specificity of oligoclonal IgG in patients infected with HIV-1 do not correlate with CNS diseaseK K Goswami, S Kaye, R Miller, et al.American Journal of Infection Control|August 23, 2015
Epidemiology of CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli among older adultsSachi Matsubayashi, Keith S Kaye, Sameen Farooq, et al.The EMBO Journal|May 1, 1984
A close association between sites of DNase I hypersensitivity and sites of enhanced cleavage by micrococcal nuclease in the 5'-flanking region of the actively transcribed ovalbumin geneJ S Kaye, M Bellard, G Dretzen, et al.Pageof 65